BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38706378)

  • 1. Pancreatic neuroendocrine tumors in French VHL mutation carriers: a multicentric retrospective study.
    Muller M; Hammel P; Couvelard A; Védie AL; Cros J; Burnichon N; Hercent A; Sauvanet A; Richard S; de Mestier L
    J Clin Endocrinol Metab; 2024 May; ():. PubMed ID: 38706378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
    Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
    Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
    Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
    Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
    Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
    Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
    Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
    Liu WK; Tian XD; Yang YM
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entries.
    Mougel G; Mohamed A; Burnichon N; Giraud S; Pigny P; Bressac-de Paillerets B; Mirebeau-Prunier D; Buffet A; Savagner F; Romanet P; Arlot Y; Gardie B; Gimenez-Roqueplo AP; Beroud C; Richard S; Barlier A
    J Med Genet; 2024 Mar; 61(4):378-384. PubMed ID: 37979962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine pancreatic tumors: guidelines for management and update.
    Burns WR; Edil BH
    Curr Treat Options Oncol; 2012 Mar; 13(1):24-34. PubMed ID: 22198808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.
    Vetrano IG; Gioppo A; Faragò G; Pinzi V; Pollo B; Broggi M; Schiariti M; Ferroli P; Acerbi F
    Adv Exp Med Biol; 2023; 1405():377-403. PubMed ID: 37452946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Hippel-Lindau and myotonic dystrophy of Steinert along with pancreatic neuroendocrine tumor and renal clear cell carcinomal neoplasm: Case report and review of the literature.
    Addeo A; Bini R; Viora T; Bonaccorsi L; Leli R
    Int J Surg Case Rep; 2013; 4(8):648-50. PubMed ID: 23774333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.
    Vibert R; Lahlou-Laforêt K; Samadi M; Krivosic V; Blanc T; Amar L; Burnichon N; Abadie C; Richard S; Gimenez-Roqueplo AP
    Eur J Hum Genet; 2022 Oct; 30(10):1171-1177. PubMed ID: 35918537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors.
    Nuñez JE; Donadio M; Filho DR; Rego JF; Barros M; Formiga MN; Lopez R; Riechelmann R
    J Gastrointest Oncol; 2019 Aug; 10(4):645-651. PubMed ID: 31392045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
    Rana HQ; Koeller DR; Schwartz A; Manning DK; Schneider KA; Krajewski KM; Choueiri TK; Lindeman NI; Garber JE; Ghazani AA
    Eur J Med Genet; 2021 Dec; 64(12):104359. PubMed ID: 34628056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel gene mutation in von Hippel-Lindau disease - a report of two cases.
    Wang J; Cao W; Wang Z; Zhu H
    BMC Med Genet; 2019 Dec; 20(1):194. PubMed ID: 31823746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
    Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
    World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.